Vivos Therapeutics Ownership | Who Owns Vivos Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Vivos Therapeutics Ownership Summary

Vivos Therapeutics is owned by 5.45% institutional investors, 23.48% insiders, and 71.06% retail investors. Vanguard group is the largest institutional shareholder, holding 2.77% of VVOS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.03% of its assets in Vivos Therapeutics shares.

VVOS Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Vivos Therapeutics	5.45%	23.48%	71.06%
Sector	Healthcare Stocks	231.98%	10.74%	-142.72%
Industry	Medical Device Stocks	37.54%	10.61%	51.85%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	304.16K	2.77%	$617.45K
Connective capital management	200.00K	2.20%	$620.00K
Drw securities	115.91K	1.06%	$235.29K
Geode capital management	56.29K	0.51%	$114.26K
B. riley wealth advisors	43.53K	0.48%	$134.95K
Commonwealth equity services	40.50K	0.37%	$82.22K
State street	24.92K	0.27%	$77.26K
Blackrock funding, inc. /de	27.82K	0.25%	$56.47K
Northern trust	12.51K	0.14%	$38.78K
Acorn wealth advisors	14.78K	0.13%	$30.00K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Connective capital management	200.00K	0.57%	$620.00K
Acorn wealth advisors	14.78K	0.01%	$30.00K
Drw securities	115.91K	0.01%	$235.29K
B. riley wealth advisors	43.53K	0.01%	$134.95K
Tower research capital llc (trc)	2.79K	0.00%	$8.66K
Commonwealth equity services	40.50K	0.00%	$82.22K
Advisor group	6.55K	-	$20.73K
Steward partners investment advisory	-	-	-
Renaissance	-	-	-
Northern trust	12.51K	-	$38.78K

Top Buyers

Holder	Shares	% Assets	Change
Vanguard group	304.16K	-	212.70K
Connective capital management	200.00K	0.57%	200.00K
Drw securities	115.91K	0.01%	74.44K
Acorn wealth advisors	14.78K	0.01%	14.78K
State street	24.92K	-	13.10K

Top Sellers

Holder	Shares	% Assets	Change
Anson funds management lp	-	-	-242.58K
Strategic wealth investment group	-	-	-100.00K
Renaissance	-	-	-39.28K
Envestnet asset management	-	-	-38.87K
B. riley wealth advisors	43.53K	0.01%	-26.00K

New Positions

Holder	Shares	% Assets	Change	Value
Connective capital management	200.00K	0.57%	200.00K	$620.00K
Acorn wealth advisors	14.78K	0.01%	14.78K	$30.00K
Fmr	40.00	-	40.00	$124.00

Sold Out

Holder	Change
Steward partners investment advisory	-8.00
Global retirement partners	-23.00
Raymond james financial	-74.00
Group one trading	-228.00
Ewa	-10.46K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	13	-40.91%	597,811	-12.95%	5	9.55%	5	-54.55%	2	-50.00%
Sep 30, 2025	20	11.11%	486,678	21.04%	5	24.47%	10	-	4	300.00%
Jun 30, 2025	17	-15.00%	401,289	-23.45%	4	12.55%	9	-25.00%	1	-
Mar 31, 2025	20	5.26%	524,220	12.11%	6	9.68%	12	100.00%	1	-
Dec 31, 2024	19	-13.64%	467,593	90.82%	7	57.86%	6	-45.45%	1	-50.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	212.70K	2.03%	-
Vanguard Institutional Extnd Mkt Idx Tr	60.63K	0.58%	-
Fidelity Extended Market Index	32.05K	0.31%	10.25K
Blackrock Extended Mkt Fund CF	27.82K	0.27%	27.82K
Extended Equity Market Fund K	23.86K	0.23%	16.00
Fidelity Total Market Index	12.07K	0.12%	-
Spartan Extended Market Index Pool E	6.21K	0.11%	242.00
Spartan Extended Market Index Pool F	6.86K	0.09%	267.00
Fidelity Series Total Market Index	8.35K	0.08%	-
Vanguard Instl Ttl Stck Mkt Idx Tr	7.40K	0.07%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 20, 2023	Huntsman Ronald Kirk	Chief Executive Officer	Buy	$7.42K
Jun 16, 2023	Huntsman Ronald Kirk	Chief Executive Officer	Buy	$5.40K
Jun 16, 2023	Huntsman Ronald Kirk	Chief Executive Officer	Buy	$2.65K
Jun 15, 2023	Huntsman Ronald Kirk	Chief Executive Officer	Buy	$10.50
Jun 14, 2023	Huntsman Ronald Kirk	Chief Executive Officer	Buy	$4.90K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q2	-	-
2023 Q2	5	-
2022 Q4	1	-
2022 Q2	1	-

VVOS Ownership FAQ

Who Owns Vivos Therapeutics?

Vivos Therapeutics shareholders are primarily institutional investors at 5.45%, followed by 23.48% insiders and 71.07% retail investors. The average institutional ownership in Vivos Therapeutics's industry, Medical Device Stocks, is 37.54%, which Vivos Therapeutics falls below.

Who owns the most shares of Vivos Therapeutics?

Vivos Therapeutics’s largest shareholders are Vanguard group (304.16K shares, 2.77%), Connective capital management (200K shares, 2.20%), and Drw securities (115.91K shares, 1.06%). Together, they hold 6.03% of Vivos Therapeutics’s total shares outstanding.

Does Blackrock own Vivos Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Vivos Therapeutics.

Who is Vivos Therapeutics’s biggest shareholder by percentage of total assets invested?

Connective capital management is Vivos Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.57% of its assets in 200K Vivos Therapeutics shares, valued at 620K$.

Who is the top mutual fund holder of Vivos Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Vivos Therapeutics shares, with 2.03% of its total shares outstanding invested in 212.7K Vivos Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools